Association of MDR1 gene polymorphisms with the risk of hepatocellular carcinoma in the Chinese Han population

Brazilian Journal of Medical and Biological Research

Volumn 46, Issue 3, 2013, Pages 311-317

  Gao, Jian ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Multidrug resistance 1 gene; Risk factors; Single nucleotide polymorphisms; Susceptibility

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CHROMOSOME VARIANT; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84876480228     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20132774     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108, doi: 10.3322/canjclin.55.2.74.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917, doi: 10.1016/S0140-6736(03)14964-1.
3. Parikh S, Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med 2007; 120: 194-202, doi: 10.1016/ j.amjmed.2006.11.020.
4. Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis 2009; 27: 80-92.
5. Chen JG, Zhang SW, Chen WQ. [Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2. Zhonghua Yu Fang Yi Xue Za Zhi 2010; 44: 383-389.
6. Zeng X, Liu S, Yu H, Ji L, Li L, Huang J, et al. DNA repair capacity, DNA-strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in southwestern Guangxi of China. DNA Cell Biol 2012; 31: 1384-1391, doi: 10.1089/dna.2012.1646.
7. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-687, doi: 10.1038/nrc1934.
8. Suriawinata A, Xu R. An update on the molecular genetics of hepatocellular carcinoma. Semin Liver Dis 2004; 24: 77-88, doi: 10.1055/s-2004-860865.
9. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16, doi: 10.1053/j.gastro.2004.09.011.
10. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14: 4300-4308, doi: 10.3748/wjg.14.4300.
11. Nault JC, Zucman-Rossi J. Genetics of hepatobiliary carcinogenesis. Semin Liver Dis 2011; 31: 173-187, doi: 10.1055/s-0031-1276646.
12. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-346, doi: 10.1038/ng0802-339.
13. Fromm MF. Genetically determined differences in Pglycoprotein function: implications for disease risk. Toxicology 2002; 181-182: 299-303, doi: 10.1016/S0300-483X(02)00297-4.
14. Gervasini G, Carrillo Jose A, Garcia M, San Jose C, Cabanillas A, Benitez J. Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer. Cancer 2006; 107: 2850-2857, doi: 10.1002/ cncr.22332.
15. Bodor M, Kelly EJ, Ho RJ. Characterization of the human MDR1 gene. AAPS J 2005; 7: E1-E5, doi: 10.1208/ aapsj070101.
16. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002; 71: 537-592, doi: 10.1146/annurev.biochem.71.102301.093055.
17. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene 2003; 22: 7468-7485, doi: 10.1038/sj.onc.1206948.
18. Jamroziak K, Mlynarski W, Balcerczak E, Mistygacz M, Trelinska J, Mirowski M, et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 2004; 72: 314-321, doi: 10.1111/ j.1600-0609.2004.00228.x.
19. Leonessa F, Clarke R. ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 2003; 10: 43-73, doi: 10.1677/erc.0.0100043.
20. Kurzawski M, Drozdzik M, Suchy J, Kurzawski G, Bialecka M, Gornik W, et al. Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol 2005; 61: 389-394, doi: 10.1007/s00228-005-0926-5.
21. Sohn JW, Lee SY, Lee SJ, Kim EJ, Cha SI, Kim CH, et al. MDR1 polymorphisms predict the response to etoposidecisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol 2006; 36: 137-141, doi: 10.1093/ jjco/hyi231.
22. Vander Borght S, Komuta M, Libbrecht L, Katoonizadeh A, Aerts R, Dymarkowski S, et al. Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin. Liver Int 2008; 28: 1370-1380, doi: 10.1111/j.1478-3231.2008.01889.x.
23. Taniguchi S, Mochida Y, Uchiumi T, Tahira T, Hayashi K, Takagi K, et al. Genetic polymorphism at the 59 regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon. Mol Cancer Ther 2003; 2: 1351-1359.
24. Yu X, Xie H, Wei B, Zhang M, Wang W, Wu J, et al. Association of MDR1 gene SNPs and haplotypes with the tacrolimus dose requirements in Han Chinese liver transplant recipients. PLoS One 2011; 6: e25933, doi: 10.1371/ journal.pone.0025933.
25. Wu L, Xu X, Shen J, Xie H, Yu S, Liang T, et al. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. J Surg Oncol 2007; 96: 62-68, doi: 10.1002/jso.20774.
26. Cavaco I, Gil JP, Gil-Berglund E, Ribeiro V. CYP3A4 and MDR1 alleles in a Portuguese population. Clin Chem Lab Med 2003; 41: 1345-1350.
27. Chinn LW, Kroetz DL. ABCB1 pharmacogenetics: progress, pitfalls, and promise. Clin Pharmacol Ther 2007; 81: 265-269, doi: 10.1038/sj.clpt.6100052.
28. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97: 3473-3478, doi: 10.1073/pnas.97.7.3473.
29. Kaya P, Gunduz U, Arpaci F, Ural AU, Guran S. Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients. Am J Hematol 2005; 80: 26-34, doi: 10.1002/ajh.20427.
30. Pechandova K, Buzkova H, Slanar O, Perlik F. Polymorphisms of the MDR1 gene in the Czech population. Folia Biol 2006; 52: 184-189.
31. Chen YD, Yang F, Feng ST, Zhang YX. A case-control study on the association between genetic polymorphisms of MDR1 and hepatic cell cancer susceptibility. Chin Clin Oncol 2009; 14: 1077-1081.
32. Chen XJ, Wang XG, Shen YJ, Zhou HK, Ni QF, Fei JG, et al. Correlation of MDR1 single nucleotide polymorphism with prognosis of hepatocellular carcinoma. J Chin Oncol 2011; 17: 209-211.
33. Yuan ZR, Li JY, Li J, Zhang L, Gao X, Gao HJ, et al. Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene 2012; 505: 190-194, doi: 10.1016/j.gene.2012.05.010.
34. Yuan ZR, Li J, Li JY, Gao X, Xu SZ. SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep 2013; 40: 7-12, doi: 10.1007/ s11033-012-1934-z.
35. Yuan ZR, Li JY, Li J, Gao X, Gao HJ, Xu SZ. Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle. Mol Biol Rep 2013; 40: 1947-1954, doi: 10.1007/s11033-012-2251-2.